Fine Tuning Risk Stratification for Atrial Fibrillation
Authors:
- Richard W. TroughtonRTRichard W. Troughton
- Ian CrozierICIan Crozier
Abstract
No abstract availableFunding Information
- Roche Diagnostics
This publication has 26 references indexed in Scilit:
- Biomarkers in atrial fibrillation: a clinical reviewEuropean Heart Journal, 2013
- Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?European Heart Journal, 2012
- Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future PrevalenceCirculation, 2006
- Atrial fibrillation: Now one of the most common causes for hospitalizationCurrent Cardiology Reports, 2005
- Lifetime Risk for Development of Atrial FibrillationCirculation, 2004
- Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UKHeart, 2004
- Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999Circulation, 2003
- Epidemiology and natural history of atrial fibrillation: clinical implicationsJACC, 2001
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesNew England Journal of Medicine, 1997
- Prevalence, Age Distribution, and Gender of Patients With Atrial FibrillationArchives of internal medicine (1960), 1995